NYSE:CPB

Campbell Soup Company (CPB)

22.66
-0.66 (2.83%)
as of Jul 6, 2026, 8:00:00 pm Market Open.
46 watching
0
Investor Insights
star iconJul 6, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Campbell Soup Company (CPB) is facing significant challenges, having declined by 22% this year and 40% in the past year. With growing concerns over the packaged food industry and shifting consumer preferences towards healthier options, the company's high dividend payout raise questions about its sustainability. While some experts suggest that CPB is currently trading at a fair valuation and could benefit from a future rotation into consumer staples, others express skepticism about its long-term viability due to reduced free cash flow and profitability pressures. The company's legacy products are becoming outdated, complicating its growth narrative, and investors are advised to consider exit strategies to mitigate losses.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
Kraft, KHC
DON'T BUY
It reported this week, stating that it's struggling with raw costs and sales growth. The stock is cheap, but not cheap enough to buy, unless management can convince. He isn't holding his breath. They hold an investors' day on Tuesday.
COMMENT
It reports Wednesday. Unsteady soup sales and climbing costs could pressure the stock, like it has before.
BUY
Recently, they missed projections and cut their forecast, so they had execution issues, but still took more market share. Covid winners are unfairly pigeonholed as reopening losers. CPB still has value. Their costs are under control.
DON'T BUY
He likes management, but the pantry stocks have been disappointing. They report Wednesday. CPB has won over enough stay-at-homers with their snacks and it pays a 3.2% yield. Overall, though, he'll pass.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly When CPB last reported earnings in Sep, EPS of $0.63 exceeded expectations by 18%. The pandemic increased soup demand by 30% and gained them over 6 million new household buyers. As we head into the the next seasonal demand upswing we are recommending them as a TOP PICK, targeting $54. It pays a good dividend, backed by a 26% payout ratio. We would recommend a stop-loss at $38. Yield 2.90% (Analysts’ price target is $53.33)
BUY
Trades at 15x earnings, pays a 3% dividend yield and generates a huge amount of cash. The stock has been slumping during the pandemic, because it's not the kind of stock you buy in an accelerating economy. Recently it announced 18% sales growth, but the stock got slammed, partially because the company didn't offer guidance for 2021 (but so have many companies).
COMMENT

A lot of bond proxies, including staples, have been under pressure. If CPB can rise above its current trend channel, we'd see a new uptrend. That's a concern, because when things go great, then people don't need to buy staples. Also, if he sees CPB move higher and break its downtrend, then it would tell him that something big is happening, that portfolio managers are becoming cautious.

BUY

Good support at $40 and currently at $46. Not what it used to be and it's very volatile. $40 is your downside protection. Volatility and volumes have spiked. Looks like a good stock here. He would slowly enter it here.

DON'T BUY

Takeover target? If this rumour had juice to it, this stock would be up higher, but an interesting idea. If there is one sector investors are complacent on, it is consumer staples. In these companies, investors are hiding in the balance sheet looking to milk the dividends because they can’t find any yield in bonds. The fact that those big stocks have low volatility and the ability to grow their dividend, is very attractive. He would avoid this stock.

COMMENT

In the consumer staple sector. There is a reduction in barriers to entry within packaged foods. He would rather be in flavouring companies, such as Fruteron (?).

DON'T BUY

He is going to steer clear of this. Had a great run close to 24 months, and has moved back as people have been rethinking the strength of brand generally. People are looking what Amazon (AMZN-Q) is doing with Whole Foods and wondering about implications for the traditional branded products, as well as about healthiness. This still has a very pricey valuation.

TOP PICK

*Short*. This trades at an expensive valuation at roughly 21X earnings. It is dependent primarily on soup, which is in secular decline, and is the high margin part of their business. A lot of it is dependent on weather. Dividend yield of 2.05%.

COMMENT

There are 2 key themes in the market. One is people who are betting on low interest rates, low inflation and low growth. In that camp, people are saying they’ll buy a dividend as opposed to a fixed income at record low yields. This is not an exciting company, but a pretty defensible one. People are buying this because it pays a 2% dividend that will slowly grow over time. It is not economically sensitive. If you believe we are in a low growth environment for a long time, these consumer staples, utilities and telcos could trade at significantly higher multiples.

PARTIAL BUY

This has been on fire, up over 40% in the last year. When looking at the sector as a whole, the names that have a large percentage of the revenue coming from North America has really been focused on increasing their awareness and product line-up in terms of healthier foods. This company has done that well. Made some acquisitions and are focusing more on the organic side of things. 75% of their revenues come from the US. He wouldn’t be opposed to buying this, but because of the run it has had you might consider buying a half position and adding more on weakness.

DON'T BUY

Kraft/Heinz deal: It put all of these companies into play in people’s minds. But he does not see a lot of value in these names.

Showing 16 to 30 of 38 entries